NCT04722029: An ongoing trial by Nationwide Children's Hospital
This trial is ongoing. It must report results 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04722029 |
|---|---|
| Title | Open-Label Pilot Study of Haploidentical Donor Adenovirus Specific T Lymphocytes (ADV-VSTS) for the Treatment of Refractory Adenovirus Infection and/or Disease in Hospitalized Patients |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 1, 2021 |
| Completion date | Oct. 1, 2024 |
| Required reporting date | Oct. 1, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |